Thema
Journal Article
28
Poly(ADP-ribose) Polymerase Inhibitors
18
BRCA1 Protein
16
Research Support, Non-U.S. Gov't
15
PARP inhibitors
13
BRCA1 protein, human
12
BRCA2 Protein
12
olaparib
12
PARP inhibitor
11
Phthalazines
11
WOH1JD9AR8
10
BRCA2 protein, human
8
Piperazines
8
Review
8
ovarian cancer
8
Randomized Controlled Trial
7
Antineoplastic Agents
6
EC 2.4.2.30
6
P88XT4IS4D
5
Paclitaxel
5
Poly(ADP-ribose) Polymerases
5
breast cancer
5
veliparib
4
01O4K0631N
3
BG3F62OND5
3
BRCA mutation
3
Benzimidazoles
3
Carboplatin
3
Clinical Trial, Phase II
3
Clinical Trial, Phase III
3
EC 2.7.10.1
3
PARP1 protein, human
3
Poly (ADP-Ribose) Polymerase-1
3
Receptor, ErbB-2
3
Research Support, N.I.H., Extramural
3
homologous recombination deficiency
3
platinum
3
2S9ZZM9Q9V
2
49DFR088MY
2
9QHX048FRV
2
BRCA
2
Bevacizumab
2
Cisplatin
2
Clinical Trial, Phase I
2
Comparative Study
2
DNA repair
2
ERBB2 protein, human
2
Multicenter Study
2
Platinum
2
Q20Q21Q62J
2
mehr ...